Abstract:Background: Rosette-Forming Glioneuronal Tumors (RGNTs) are rare, typically benign central nervous system tumors primarily located in the fourth ventricle and pineal region. Despite being classified as WHO grade I with generally favorable prognoses, RGNTs present complexities in their molecular mechanisms, occasional malignant transformation, and epidemiological characteristics that require further investigation. Method: This study systematically reviews the existing literature to analyze the epidemiological patterns, MRI characteristics, pathological features, diagnostic challenges, and molecular mechanisms associated with RGNTs, aiming to provide a comprehensive theoretical foundation for clinical practice and future research. Results: Through an in-depth review of recent studies, key molecular mechanisms, including mutations in FGFR1, PIK3CA, TERT, and IDH1/2, are highlighted. Additionally, the challenges in accurate diagnosis and the potential for misdiagnosis are discussed, emphasizing the importance of thorough molecular analysis in clinical settings. The literature indicates that RGNTs predominantly affect young adults and adolescents, with a slight female predominance. MRI typically reveals mixed cystic–solid lesions, often accompanied by hydrocephalus. Pathologically, RGNTs are characterized by a combination of neuronal and glial components, with immunohistochemical staining showing positivity for Synaptophysin and GFAP. High frequencies of FGFR1 and PIK3CA mutations underscore the significance of these pathways in RGNT pathogenesis and progression. Although RGNTs generally exhibit low malignancy, the TERT mutations identified in some cases suggest a risk of malignant transformation. Conclusions: This study concludes that while current treatment strategies focus on surgical resection, integrating molecular diagnostics and targeted therapies may be essential for managing recurrent or refractory RGNTs. Future research should explore the impact of various gene mutations on tumor behavior and their correlation with clinical outcomes, to optimize individualized therapeutic strategies and improve patient survival and quality of life.

New Variants of Mixed Glioneuronal Tumors in Central Nervous System

Clinicopathological features and surgical treatment in patients with central neurocytoma

Granular cell tumor:a clinicopathologic analysis of 15 cases

Primary Melanocytoma of Central Nervous System:A Clinicopathologic Analysis of Two Cases

Computed tomography and pathological findings of five nasal neurilemmomas

Glial Malignancies

Glioneuronal and neuronal tumors: A perspective

One Case of Myxoid Glioneuronal Tumour in the Left Frontal Lobe

The 2021 WHO Classification of Tumors of the Central Nervous System: An update on pediatric low‐grade gliomas and glioneuronal tumors

Papillary glioneuronal tumor: A rare case with recent updates as per 2021 CNS WHO 5th classification

CNS Germ Cell Tumors: Molecular Advances, Significance in Risk Stratification and Future Directions

Novel insights toward diagnosis and treatment of glioneuronal and neuronal tumors in young adults

Granular Cell Tumor of the Neurohypophysis: 3 Cases and a Systematic Literature Review of 98 Cases.

Germ cell tumors with neuroglial differentiation do not show molecular features akin to their central nervous system counterpart: experience from extra-gynecological sites

Germ cell tumors of the central nervous system: A brief review and site-specific considerations

An Update on Neurofibromatosis Type 1-Associated Gliomas

Imaging Findings of Newly Augmented Tumors and Tumor Subtypes in the 2007 Revised WHO Central Nervous System Tumor Classification (Report of Six Cases)

Hybrid schwannoma–perineurioma frequently harbors VGLL3 rearrangement

The Clinical and Molecular Landscape of Rosette-Forming Glioneuronal Tumors

Novel molecular subtypes of intracranial germ cell tumors expand therapeutic opportunities

Rare presentations of glioblastoma multiforme in the septum pellucidum: illustrative case